Additionally, plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) have emerged as potential biomarkers for AD and other neurodegenerative diseases, further expanding the potential of blood‐based diagnostics.14 Here, GFAP is linked to neurodegenerative disease.